Amneal Pharmaceuticals (AMRX) is recalling three lots of sulfamethoxazole/trimethoprim tablets due to microbial contamination, the US Food and Drug Administration said Wednesday.
The recall was issued after a product quality complaint over the appearance of black spots on the tablet surface, the FDA said.
The lots in question were distributed nationwide to wholesalers and distributors between December 4, 2024 and May 15, 2025, according to the FDA.
The tablets are used for the treatment of urinary tract infections.
Price: 7.41, Change: -0.04, Percent Change: -0.60
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。